High-Volume Scanners

PRODUCTS

  • At Ideagen, we're committed to empowering seamless collaboration and enhancing your document review process. Through strategic alliances with leading technology providers across the life science industry, we offer integrations that amplify the efficiency and effectiveness of your workflows.

  • Accelerate your path to success with NetSuite by leveraging a top 3 NetSuite Partner in the world.

    5 star, award-winning support in your corner

    Optimize NetSuite for your industry, based on best practices, and get sound recommendations regarding processes and user scenarios based on years of expertise. We help our NetSuite clients and potential clients see what’s possible, set priorities, create a roadmap for accomplishment, and deliver results that matter.

    When you choose Sikich, you choose a dedicated team of NetSuite consultants who spent years in a specific industry before they joined us, and who are committed to making a vital contribution to your business.

    Get the connected, available and accountable support that your organization deserves by joining the ranks of our highly satisfied clients.

  • Addressing Modern mAb Purification Challenges

    The latest protein A resin from Purolite, an Ecolab company, DurA Cycle A50 aims to maximize productivity and improve process economics.

    DurA Cycle A50 improves purification performance with high capacities, which can help to enable a lower cost per gram of commercial drug product. Building on the innovation of Praesto™ Jetted A50 HipH, DurA Cycle A50 provides a wider elution pH window to address aggregate clearance.

  • Buffer management solutions that reduce costs and expand possibilities.

    Buffers play a significant role in biopharmaceutical manufacturing. They represent the major component by number and overall volume used in biopharma downstream processing steps. Buffer preparation makes up a substantial portion of a facility’s footprint and overall cost, labor requirements, and equipment.

  • In the aftermath of the COVID-19 pandemic, clinical laboratories were faced with an urgent need to rapidly expand their testing capacity. Given the importance of disease surveillance in a public health crisis, Germfree's priority was to quickly create a series of rapidly deployable laboratory spaces that could be used for disease surveillance in emergencies, as temporary laboratory spaces, and as swing spaces.

WHITE PAPERS AND CASE STUDIES

NEWS